From Trials to Bedside: Filling the Gaps in Implementing Evidence-based Care

State of the Science: The Six Pillars of Heart Failure Therapy

A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3

Prevalence and Prediction of Coronary Artery Disease in the General Population- Results From the Swedish Cardiopulmonary Bioimage Study (scapis)

A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial

Putting it all Together in Lipid Therapy

3-year Clinical Outcomes in a Nationwide, Randomized, Pragmatic Clinical Trial of Atrial Fibrillation Screening - Mhealth Screening to Prevent Strokes (mstops)

High Dose versus Standard Dose Influenza Vaccine in Patients With High Risk Cardiovascular Disease: Results From the Invested Trial

Rate versus Rhythm Control - lessons learned from EAST

The Vital Rhythm Trial: Omega-3 Fatty Acid and Vitamin D Supplementation in the Primary Prevention of Atrial Fibrillation

The AHA COVID-19 Cardiovascular Disease Registry: Design, Implementation, and Initial Results

Early Invasive Intervention for Atrial Fibrillation

Aspirin Alone and in Combination With a Polypill in Cardiovascular Disease Primary Prevention: Results From the International Polycap Study (TIPS)-3

The Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia

State of the Art in Anti-Coagulation Management for Difficult Cases

2020 AHA Guidelines on ECC and CPR - Adult Basic and Advanced Life Support